Lookup NU author(s): Dr Lei Huang,
Dr Henrique De Paula Lemos,
Professor Andrew Mellor
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Enhanced amino acid catabolism is a common response to inflammation, but the immunologic significance of altered amino acid consumption remains unclear. The finding that tryptophan catabolism helped maintain fetal tolerance during pregnancy provided novel insights into the significance of amino acid metabolism in controlling immunity. Recent advances in identifying molecular pathways that enhance amino acid catabolism and downstream mechanisms that affect immune cells in response to inflammatory cues support the notion that amino acid catabolism regulates innate and adaptive immune cells in pathologic settings. Cells expressing enzymes that degrade amino acids modulate antigen-presenting cell and lymphocyte functions and reveal critical roles for amino acid- and catabolite-sensing pathways in controlling gene expression, functions, and survival of immune cells. Basal amino acid catabolism may contribute to immune homeostasis that prevents autoimmunity, whereas elevated amino acid catalytic activity may reinforce immune suppression to promote tumorigenesis and persistence of some pathogens that cause chronic infections. For these reasons, there is considerable interest in generating novel drugs that inhibit or induce amino acid consumption and target downstream molecular pathways that control immunity. In this review, we summarize recent developments and highlight novel concepts and key outstanding questions in this active research field.
Author(s): McGaha TL, Huang L, Lemos H, Metz R, Mautino M, Prendergast GC, Mellor AL
Publication type: Review
Publication status: Published
Journal: Immunological Reviews
Print publication date: 01/09/2012
ISSN (print): 0105-2896
ISSN (electronic): 1600-065X
PubMed id: 22889220